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A cancer-associated point mutation 
disables the steric gate of human 
primpol
Alberto Díaz-talavera1, patricia A. Calvo1, Daniel González-Acosta2, Marcos Díaz2, 
Guillermo sastre-Moreno1, Luis Blanco-Franco1, susana Guerra1, Maria I. Martínez-Jiménez1, 
Juan Méndez2 & Luis Blanco  1
primpol is a human primase/polymerase specialized in re-starting stalled forks by repriming beyond 
lesions such as pyrimidine dimers, and replication-perturbing structures including G-quadruplexes and 
R-loops. Unlike most conventional primases, PrimPol proficiently discriminates against ribonucleotides 
(NTPs), being able to start synthesis using deoxynucleotides (dNtps), yet the structural basis and 
physiological implications for this discrimination are not understood. In silico analyses based on the 
three-dimensional structure of human primpol and related enzymes enabled us to predict a single 
residue, tyr100, as the main effector of sugar discrimination in human PrimPol and a change of Tyr100 
to histidine to boost the efficiency of NTP incorporation. We show here that the Y100H mutation 
profoundly stimulates NTP incorporation by human PrimPol, with an efficiency similar to that for dNTP 
incorporation during both primase and polymerase reactions in vitro. As expected from the higher 
cellular concentration of NTPs relative to dNTPs, Y100H expression in mouse embryonic fibroblasts and 
U2OS osteosarcoma cells caused enhanced resistance to hydroxyurea, which decreases the dNTP pool 
levels in S-phase. Remarkably, the Y100H PrimPol mutation has been identified in cancer, suggesting 
that this mutation could be selected to promote survival at early stages of tumorigenesis, which is 
characterized by depleted dNtp pools.
Incorporation of ribonucleoside triphosphates (NTPs) onto DNA is generally considered harmful, because the 
persistence of ribonucleoside monophosphates (NMPs) in the DNA is associated with several potential problems: 
(1) NMPs are non-canonical templates for DNA replication1–3; (2) the assembly of nucleosomes is impeded by 
the presence of NMPs4; (3) NMPs embedded in the DNA are more prone to hydrolysis than deoxynucleosides 
monophosphates (dNMPs) and consequently render the DNA backbone more labile5; and (4) a single NMP 
embedded in the DNA duplex can result in helix perturbation and can alter protein recognition and binding6,7. 
Most DNA polymerases, in particular those specialized in bulk DNA replication, efficiently discriminate in favor 
of dNTPs, which reflects the hazardous potential of NTPs2,8,9. To distinguish NTPs from dNTPs, DNA polymer-
ases are commonly endowed with “steric gates” formed by residues with bulky side chains, such as tyrosine or 
tryptophan, which sterically hinder the access of NTP into the active site via collision with the 2′ hydroxyl group 
(2′OH). However, the exclusive use of dNTPs by DNA polymerases is a difficult challenge because NTPs are far 
more abundant in cells than dNTPs10. Indeed, recent studies demonstrated that despite their ability to discrimi-
nate against NTPs, replicases incorporate these substrates at strikingly high rates in vivo (e.g. around 1 per 1 kb in 
the case of yeast Polε) because of their high cellular concentration11.
Nonetheless, this incorporation of NTPs is not necessarily hazardous as single embedded NMPs are efficiently 
removed by the ribonucleotide excision repair pathway12, which is initiated by RNase H2, an enzyme essential 
to preserve genomic stability in mammals13. Interestingly, likely due to the transient nature of NMPs in DNA, 
the incorporation of NTPs into DNA is physiologically relevant and even beneficial in several biological pro-
cesses, for example by contributing to mismatch repair signalling14,15, improving the fidelity of Polμ-mediated 
non-homologous end joining in vitro16, mediating error-free tolerance of 8-oxo-dexyguanosine (8oxoG) in 
Schizosaccharomyces pombe17, and even mediating mating-type switching also in fission yeast18. Overall, spe-
cialized polymerases involved in translesion synthesis (TLS) can exploit a relaxed steric gate, allowing the use 
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of ribonucleotides as alternative substrates to bypass DNA lesions19. A special scenario implies the recurrent 
synthesis of short chains of NMPs (RNA primers) generated by conventional primases to prime DNA replication 
that are accurately removed20–22.
PrimPol is a novel human primase/polymerase belonging to the Archeal-Eukaryotic-Primase (AEP) super-
family23 that is specialized in re-priming at stalled forks to re-start DNA replication downstream of UV damaged 
sites24,25, G quadruplexes26 and even R-loops27. PrimPol, which localizes to both mitochondria and nuclei of 
human cells, displays both primase and polymerase activities23. As a polymerase, PrimPol efficiently tolerates 
different DNA template lesions in vitro by either incorporating nucleotides opposite them or beyond the dam-
aged site in the case of unreadable lesions such as pyrimidine dimers23,24; however, the physiological relevance of 
this polymerase activity is not well understood. Conversely, it is well established that PrimPol primase activity is 
relevant to mediate replication re-start at stalled forks24,28, and this appears to be its main role in vivo. Whereas 
PrimPol accepts both ribo and deoxynucleotides at the initiation site29, unlike unconventional primases it effi-
ciently discriminates against NTPs at the elongation site, to incorporate dNTPs with much higher efficiency23. 
Accordingly, human PrimPol must have structural elements to discriminate against the use of NTPs, although 
the basis for such discrimination and the physiological relevance of PrimPol preference for dNTP incorporation 
remain unknown.
In this work, we have identified a single residue, Tyr100, as the main mediator of sugar discrimination in 
human PrimPol. Structural analyses and sequence comparison with other members of the AEP superfamily ena-
bled us to predict and demonstrate that a change of Tyr100 to histidine frees PrimPol to efficiently incorporate 
NTPs during polymerase and primase reactions in vitro, and provides increased resistance to downregulation 
of dNTP pools during DNA replication in murine embryonic fibroblasts (MEFs) and U2OS osteosarcoma cells. 
Remarkably, the very same mutation in PrimPol (Y100H) has been identified in lung cancer30, suggesting its 
implication to promote survival during the tumorigenesis process.
Results
Identification of Tyr100 as a potential sugar selector in human primpol. To identify the residue/s 
that mediate sugar discrimination in human PrimPol we compared the primary sequences of biochemically char-
acterized and crystallized AEP members with preference for either dNTP or NTP incorporation. Pyrococcus 
furiosus p41 (Pfu-p41), an archeal primase/polymerase31–33, was chosen as an AEP with preference for dNTPs, 
similar to human PrimPol34; in turn, Mycobacterium tuberculosis PolDom (MtPolDom), the polymerase domain 
in Ligase D, a multi-domain protein specialized in non-homologous end joining (NHEJ)35–37, was chosen as an 
AEP with preference for NTP insertion. Multiple alignment of the primary sequence encompassing the highly 
conserved Motif A and its upstream flanking region (Fig. 1a) showed that MtPolDom His111, a candidate residue 
to facilitate NTP incorporation35–37, is not conserved but substituted by a tyrosine in Pfu-p41 (Tyr72) and human 
PrimPol (Tyr100).
Analysis of the crystal structure of MtPolDom indeed demonstrated that His111 interacts with the 2′OH group 
of the sugar moiety of the incoming NTP, possibly mediating its stabilization as a preferred substrate (Fig. 1b). 
Remarkably, Pfu-p41 Tyr72 and human PrimPol Tyr100 are located in a similar position to MtPolDom His111 in 
their respective crystal structures (Fig. 1b), suggesting that they could also affect sugar selection. Moreover, the 
fact that tyrosines are bulkier than histidines supports a role in excluding NTPs by steric hindrance rather than 
stabilizing these substrates in the active site, which could explain the difference in sugar selectivity between 
human PrimPol/Pfu-p41 and MtPolDom. Notably, MtPolDom His111, Pfu-p41 Tyr72 and human PrimPol Tyr100, 
are all highly conserved among orthologs through evolution (Supplemental Fig. 1), further supporting a relevant 
role for these residues in substrate selection. Taken together, these in silico analyses suggest that human PrimPol 
Tyr100 could be a relevant mediator of sugar discrimination, and that mutation of this residue to histidine could 
boost NTP incorporation. Remarkably, a previous study30 compiled in the COSMIC database (http://cancer.
sanger.ac.uk/cosmic)38, identified the Y100H mutation of human PrimPol in a lung tumor sample, which further 
prompted us to evaluate the effect of this mutation on sugar discrimination.
Mutant Y100H can efficiently elongate primers with NTPs. The effect of the Y100H mutation on 
sugar discrimination was firstly tested in primer extension in vitro assays, in which either the purified mutant 
or the wild-type (WT) PrimPol were incubated with a labelled DNA primer/DNA template molecule and either 
dNTPs of NTPs as substrates. As previously reported23,39, WT PrimPol could efficiently extend the primer using 
dNTPs, and displayed barely detectable activity using NTPs (Fig. 2a). In striking contrast, the Y100H mutation 
markedly increased the efficiency of NTP incorporation, which reached levels similar to those for dNTP insertion 
(Fig. 2a), demonstrating that the mutation enhances NTP incorporation in DNA primer extension reactions. Of 
note, the Y100H mutation slightly hampered dNTP incorporation when compared with the WT control (Fig. 2a), 
further suggesting that Tyr100 is relevant for the optimal incorporation of dNTP substrates.
We have previously showed that PrimPol can also extend RNA primers paired to DNA templates in vitro, 
suggesting a potential uncharacterized function in assisting transcription39. Thus, we sought to explore the effect 
of the Y100H mutation in this transcription-like reaction. As expected when the DNA primer was replaced by an 
equivalent RNA primer (Fig. 2b), WT PrimPol preferably extended the RNA primer with dNTPs. Interestingly, 
the Y100H mutation largely stimulated the efficiency of RNA primer extension with NTPs (Fig. 2b), overpassing 
the efficiency of RNA primer extension with dNTPs, thereby demonstrating the relevance of Tyr100 to regulate 
sugar selection by PrimPol.
Overall, the Y100H mutation did not significantly affect the proper base selection of both incoming dNTPs 
(Fig. 2c) and NTPs (Fig. 2d), preferentially inserting the complementary (Watson-Crick) nucleotide dictated by 
the first available template base. Nevertheless, under the assay conditions used, Y100H made less errors than WT 
PrimPol when using relatively similar amounts of dNTPs (Fig. 2c), but more errors with NTPs, even when WT 
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PrimPol was assayed at a 20-fold higher NTP concentration (Fig. 2d). As it will be shown later in this section, this 
alteration in the sugar selectivity of inserted errors is the direct consequence of a more equilibrated NTP/dNTP 
discrimination ratio than that displayed by WT PrimPol. Accordingly, the level of ribonucleotide errors inserted 
in vivo by the Y100H variant is expected to be even higher, given the superior concentration of ribonucleotides 
versus deoxynucleotides inside cells. In vitro analysis of misinsertion by Y100H using physiological concentra-
tions of ribonucleotides10 supports this prediction (see Supplemental Fig. 2).
Although the physiological relevance of PrimPol polymerase activity is not well understood, it is thought to 
be associated with a role in damage tolerance, by virtue of PrimPol efficient TLS activity in vitro23,40. A relevant 
scenario is the bypass of 8-oxoguanine (8oxoG), a highly pre-mutagenic lesion that PrimPol tolerates by incor-
porating dCTP (error-free) or dATP (error-prone) with similar efficiency to the insertion of dCTP opposite an 
undamaged dG23,41; Fig. 2e). Interestingly, and due to its improvement in NTP incorporation, the Y100H mutant 
was not only able to insert dCTP and dATP opposite the lesion, but also the corresponding ribonucleotides CTP 
and ATP (Fig. 2e).
To unravel the basis for sugar discrimination by PrimPol, and also for the improvement in NTP incorporation 
produced by the mutation Y100H, we performed steady-state kinetic analyses of deoxy versus ribonucleotide 
incorporation opposite either undamaged template bases dG and dT or 8oxoG. These studies demonstrated that 
WT PrimPol discriminates against ribonucleotides (NTP/dNTP discrimination values were in the range of 0.05 
to 0.01; see Table 1) mainly due to their lower affinity (higher Km) compared with dNTPs: 11-fold (CTP/dCTP 
opposite dG), 47-fold (ATP/dATP opposite dT), 41-fold (CTP/dCTP opposite 8oxoG), and 28-fold (ATP/dATP 
opposite 8oxoG). As the kcat values for NTP versus dNTP incorporation were only moderately decreased (2.3- to 
6-fold), we conclude that a steric gate is the main responsible for the human PrimPol discrimination against 
ribonucleotides. A similar conclusion can be inferred from a previous report studying sugar selectivity of human 
PrimPol42.
In contrast with WT PrimPol, mutant Y100H displayed a more equilibrated NTP/dNTP discrimination ratios 
(between 0.72 and 1.73) resulting in a 32-fold to 173-fold improvement in NTP insertion (see Table 1). This was 
Figure 1. Prediction of the sugar selector in human PrimPol. (a) Primary sequence comparison of the region 
encompassing motif A of MtPolDom, Pfu-p41 and HsPrimPol. Catalytic residues involved in metal binding are 
indicated with red dots. Single residues acting as a sugar selector favoring NTPs or dNTPs are indicated with 
violet or pink dots, respectively; β-strands are indicated as light blue arrows. Figures in parenthesis indicate the 
number of N-terminal or C-terminal amino acid residues that are not shown. Invariant (red) or conserved (bold 
black) residues are indicated (see also Supplemental Fig. 1). (b) Structural details of the region aligned in part 
a, containing candidate residues to act as sugar selectors, and two catalytic metal ligands; a third metal ligand, 
embedded in an additional peptide segment (motif C; depicted in dark blue) is also shown in MtPolDom (PDB 
ID: 3PKY, DNA template/primer from 4MKY and NTP from 3PKY), Pfu-p41 (PDB ID: 1G71, DNA template/
primer and dNTP from 5L2X) and HsPrimPol (PDB ID: 5L2X, DNA template/primer and dNTP from 5L2X).
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mainly due to a gain in affinity for NTPs (a large decrease in Km) relative to WT PrimPol: 13-fold (CTP opposite 
dG), 36-fold (ATP opposite dT), 29-fold (CTP opposite 8oxoG), and 21-fold (ATP opposite 8oxoG). The kcat val-
ues for NTP incorporation (Y100H vs WT PrimPol) were only slightly improved (1- to 4-fold). These data support 
the role of Tyr100 as a steric gate residue, which defines PrimPol’s preference for dNTPs as incoming nucleotides. 
Interestingly, the catalytic efficiency for dNTP incorporation was only moderately decreased as a consequence of 
Figure 2. Use of ribonucleotides by the Y100H variant during primer extension and translesion synthesis. (a) 
DNA primer extension assay on the indicated template/primer by either wild-type (WT) PrimPol or Y100H, 
using increasing concentration of dNTPs (1, 10, 50 µM) or NTPs (1, 10, 50 µM). (b) RNA primer extension on 
the indicated template/ RNA primer structure as described in part a. (c) Matched versus mismatched nucleotide 
insertion at the four template bases (indicated as X in the scheme). Nucleotide insertion on each template-
primer was analyzed in the presence of each individual dNTP at 1 µM or 5 µM for the WT or Y100H mutant 
respectively. (d) As described in (c), using NTP as substrates at 100 µM or 5 µM for the WT or Y100H mutant 
respectively. (e) Lesion bypass of 8oxoG (scheme of the template/primer structure at the top) by either WT 
PrimPol or Y100H (100 nM) in the presence of 100 µM MnCl2 as metal cofactor with increasing concentrations 
(1, 10, 50 µM) of dCTP or CTP (upper panel) and dATP or ATP (lower panel). (f) Lesion bypass of a CPD 
lesion (scheme of the template/primer structure at the top) of either WT PrimPol or Y100H with increasing 
concentrations of dNTPs or NTPs (1, 10, 100 µM). Full length gels corresponding to parts a, b, e and f are shown 
in Supplemental Fig. 5. The autoradiographs shown in this figure are representative of at least 3 independent 
experiments.
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the Y100H mutation, with the exception of the insertion of dCTP opposite 8oxoG (4.1-fold), which is largely due 
to a 3-fold increase in Km. This suggests that Tyr100 is specifically required to optimize the error-free insertion of 
dCTP opposite 8oxoG.
PrimPol efficiently bypasses other lesions such as apurinic/apyrimidinic sites23 and thymidine dimers such as 
cyclobutane pyrimidine dimers (CPD) or 6–4 photoproducts24. Unlike TLS on 8oxoG, the bypass of these other 
lesions relies on PrimPol’s exceptional capacity to realign a matched primer terminus at downstream micro-
homologies found beyond the lesion, a process referred to as pseudo-TLS24,39. Remarkably, WT PrimPol was 
unable to catalyze pseudo-TLS with NTPs for bypassing CPDs (Fig. 2f), abasic sites or a 6–4 photoproducts 
(Supplemental Fig. 3). Conversely, the improvement in NTP binding by the Y100H mutation facilitated the effi-
cient bypass of these lesions with ribonucleotides (Fig. 2f and Supplemental Fig. 3). Of note, the mutation again 
decreased the overall efficiency of TLS with dNTPs as compared with the WT control (Fig. 2f and Supplemental 
Fig. 3).
In conclusion, these analyses demonstrate that the Y100H mutation greatly increases the efficiency of NTP 
incorporation during primer extension in vitro by PrimPol, facilitating the use of these substrates also during 
PrimPol-mediated TLS.
The Y100H mutation allows the efficient synthesis of RNA primers. To evaluate the effect of the 
human PrimPol Y100H mutation on sugar discrimination during initiation of primer synthesis, we used a 29-mer 
ssDNA template containing a single and preferred priming site (3′-GTCA-5′), flanked by homopolymeric tracks 
of Ts. PrimPol efficiently starts synthesis on this template by generating a 3pAdG dinucleotide opposite the TC 
templating bases (see scheme in Fig. 3a), which is the initial and rate-limiting catalytic step during primer syn-
thesis29. To form the initiating dimer, both WT PrimPol and mutant Y100H similarly used [α-32P]dATP at the 
5′ initiation site and dGTP at the 3′ elongation site, but only the Y100H mutant formed a dimer when dGTP was 
replaced by GTP (Fig. 3a, upper panel). Thus, in agreement with the conclusions drawn from the primer exten-
sion assays, the Y100H mutant lacks ribose discrimination at the 3′ site also during dimer formation. As expected 
from the lack of sugar discrimination at the initiation site, both WT PrimPol and Y100H could efficiently cata-
lyze the generation of a 3pAdG dinucleotide (using [ϒ-32P]ATP instead of [α-32P]dATP at the 5′ position) and 
dGTP at the 3′ position (Fig. 3a, lower panel); but again, only mutant Y100H was able to use GTP at the 3′ site, 
generating the dimer 3pAG. Altogether, these results indicate that sugar selection by WT PrimPol during dimer 
formation requires Tyr100, but it only operates on the elongating nucleotide (3′site). Replacement of Tyr100 by a 
histidine abolishes this discrimination and balances the efficiency of dNTP and NTP insertion.
To delineate the basis for sugar discrimination during primer synthesis by WT PrimPol or the Y100H var-
iant, we next analyzed two individual steps preceding dimer formation29. Analysis of enzyme:ssDNA binary 
complex formation, as determined by EMSA with a ssDNA template containing a preferred and single priming 
site (3′-GTCC- 5′; see Methods), demonstrated that WT PrimPol and mutant Y100H have the same affinity for 
ssDNA (Fig. 3b). After forming a stable binary complex, and before catalyzing the initiating dimer, most primases 
firstly bind the 3′-site nucleotide (at the elongation site) and subsequently the 5′-site nucleotide (at the primer 
Template PrimPol
NTP or 
dNTP Km (µM) kcat (s−1)
Catalytic efficiency 
kcat/Km (s−1 µM−1)
Discriminationa 
(NTP vs dNTP)
Improvedb NTP 
preference
Improvedc 
NTP Binding
dG
WT
CTP 9.08 ± 0.87 (3.08 ± 0.04) · 10−3 (0.34 ± 0.04) · 10−3
0.05
32-fold 13-fold
dCTP 0.84 ± 0.05 (5.83 ± 0,11) · 10−3 (6.94 ± 0.57) · 10−3
Y100H
CTP 0.69 ± 0.08 (3.24 ± 0.11) · 10−3 (4.73 ± 0.73) · 10−3
1.58
dCTP 0.92 ± 0.20 (2.75 ± 0.17) · 10−3 (3.00 ± 0.83) · 10−3
dT
WT
ATP 38.68 ± 3.64 (0.97 ± 0.02) · 10−3 (0.03 ± 0.003) · 10−3
0.01
72-fold 36-fold
dATP 0.78 ± 0.12 (3.18 ± 0.13) · 10−3 (4.05 ± 0.80) · 10−3
Y100H
ATP 1.06 ± 0.12 (2.67 ± 0.09) · 10−3 (2.51 ± 0.36) · 10−3
0.72
dATP 0.65 ± 0.21 (2.26 ± 0.18) · 10−3 (3.47 ± 1.42) · 10−3
8oxodG
WT
CTP 34.36 ± 2.70 (1.72 ± 0.04) · 10−3 (0.05 ± 0.005) · 10−3
0.01
173-fold 29-fold
dCTP 0.83 ± 0.13 (3.91 ± 0.19) · 10−3 (4.72 ± 0.98) · 10−3
Y100H
CTP 1.17 ± 0.10 (2.36 ± 0.07) · 10−3 (2.01 ± 0.23) · 10−3
1.73
dCTP 2.56 ± 0.65 (2.98 ± 0.35) · 10−3 (1.16 ± 0.43) · 10−3
WT
ATP 20.86 ± 5.68 (0.62 ± 0.03) · 10−3 (0.03 ± 0.01) · 10−3
0.01
75-fold 21-fold
dATP 0.75 ± 0.09 (3.72 ± 0.12) · 10−3 (4.95 ± 0.73) · 10−3
Y100H
ATP 1.01 ± 0.22 (2.49 ± 0.17) · 10−3 (2.47 ± 0.72) · 10−3
0.75
dATP 0.75 ± 0.19 (2.45 ± 0.17) · 10−3 (3.27 ± 1.06) · 10−3
Table 1. Pre-steady state kinetic parameters for deoxy- vs ribonucleotide incorporation. WT PrimPol or 
Y100H mutant kinetic parameters (Km, kcat, and catalytic efficiency) were calculated for the insertion of single 
nucleotides (CTP, dCTP, ATP and dATP) opposite a templating G, T or 8oxoG, as described in Methods. aNTP/
dNTP discrimination ratio is calculated by dividing the catalytic efficiency of ribo vs deoxy versions of a given 
nucleotide. bImproved NTP preference ratio (Y100H mutant relative to WT PrimPol) is calculated by dividing 
the discrimination values for a given nucleotide. cImproved NTP binding ratio (Y100H mutant relative to WT 
PrimPol) is calculated by dividing the Km values for a given ribonucleotide.
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site). Formation of such a transient pre-ternary complex with the 3′ nucleotide has been recently demonstrated 
for human PrimPol using EMSA assays with radiolabeled nucleotides29. Thus, we could analyze sugar discrimina-
tion during pre-ternary complex formation by performing EMSA with a 60-mer ssDNA template [3′-GTCC-5′] 
and labelled [α-32P]dGTP or [α-32P]GTP. As shown in Fig. 3c (left panel), WT PrimPol was only able to pro-
duce a pre-ternary complex with [α-32P]dGTP, indicating that a steric gate precludes GTP binding at the 3′ site. 
Conversely, the Y100H mutant could form a stable pre-ternary complex using a ribonucleotide ([α-32P]GTP; 
see Fig. 3c, right panel), hence explaining the enhanced primase activity of the mutant using ribonucleotides. 
However, the Y100H mutation decreased formation of a pre-ternary complex with [α-32P]dGTP (as compared 
with WT PrimPol), suggesting that Tyr100 is required for maximal stability of dNTPs at the elongation site also 
during primer synthesis.
Finally, to analyze the formation of mature primers, we used a similar primase assay but this time with a vari-
ation of the DNA template sequence (3′-GTCAGACAGCA-5′) flanked by polydT tails (Fig. 3d). Consistent with 
the previous result, WT PrimPol and Y100H were able to make similar amounts of dimers, trimers and further 
elongated DNA primers when provided with the necessary deoxynucleotides (Fig. 3d). By contrast, only mutant 
Y100H was able to initiate and elongate RNA primers, reaching a similar and even longer mature size as DNA 
primers on the template sequence (Fig. 3d).
As shown here, and unlike WT PrimPol, the Y100H variant is able to make a full primer with NTPs, as a result 
of its loss of sugar discrimination at the 3′site together with PrimPol´s ability to extend an RNA primer. Thus, 
considering the high in vivo concentration of NTPs, it is tempting to speculate that the tumoral Y100H variant 
would execute its re-priming function during replication stress by synthesizing all-RNA primers.
Figure 3. Ribonucleotides are valid substrates for the Y100H variant during primer synthesis. (a) Scheme on 
the top shows PrimPol in complex with the GTCA template oligonucleotide and the two nucleotides forming 
the initial dimer. The autoradiograph shows dimer formation (primase activity) either by wild-type (WT) 
PrimPol or Y100H (400 nM) using [α-32P]dATP (upper panel) or [γ-32P]ATP (lower panel) as the 5′-site 
nucleotide (16 nM), and increasing concentrations of either dGTP or GTP as the incoming 3′-site nucleotide 
(0, 10, 50, 100 µM). (b) Binary complex formation, measured by EMSA, between WT PrimPol or Y100H and 
labeled 60-mer DNA template GTCC (1 nM), using the indicated PrimPol concentration (2.5, 5, 10, 20, 40 and 
80 nM) (c) Pre-ternary complex formation measured by EMSA between WT PrimPol or Y100H (1 µM), 60-mer 
DNA template GTCC and either [α-32P]dGTP or [α-32P]GTP (16 nM). (d) DNA or RNA primers synthesized 
using as template 5′-T20ACGACAGACTGT29 -3′ to allow elongation beyond the dimer. Products were labeled 
with [γ-32P]ATP (16 nM) as the 5′nucleotide and each subsequent nucleotide (dGTP, dTTP, dCTP) was added 
(10 µM) as indicated in the figure. Full length gels corresponding to parts a to d are shown in Supplemental 
Fig. 6. The autoradiographs shown in this figure are representative of at least 3 independent experiments.
www.nature.com/scientificreports/
7Scientific RepoRts |          (2019) 9:1121  | https://doi.org/10.1038/s41598-018-37439-0
Y100H variant is competent for re-priming in vivo. PrimPol assists DNA replication by re-priming 
ahead of stalled forks to reinitiate DNA synthesis24–26,43, and this is arguably its main physiological role. The 
importance of this function is revealed by a drop in the rate of fork progression, as determined by DNA fiber 
analysis after doxycycline-mediated induction of PrimPol shRNA24; see also Fig. 4a). Normal fork rate can be 
re-established by ectopic expression of WT PrimPol (V5-WT in Fig. 4a), but not by a primase-deficient mutant24. 
Interestingly, ectopic expression of the Y100H mutant (V5-Y100H in Fig. 4a) also recovered normal fork rate, 
suggesting that a change in sugar selectivity affecting primer synthesis does not impede its normal function in 
vivo. Expression levels of WT and Y100H PrimPol versions were comparable in these experiments (see immu-
noblots in Supplemental Fig. 4a).
Inside cells, the concentration of nucleotides is highly asymmetrical, with the concentration of NTPs much 
higher than that of dNTPs10. Given that the Y100H variant lacks discrimination against NTPs, it would expected 
to be more proficient than WT PrimPol when making primers under physiological concentration of nucleotides. 
To test this idea, we estimated primase efficiency by quantifying the dimers formed on the 3′ (T)nGTCA(T)n 
5′ template when providing [γ-32P]ATP as the initiating nucleotide and different ratios of dGTP and GTP as 
competing 3′ nucleotides. Importantly, 3pAdG and 3pAG dimers formed in the same reaction could be resolved 
after electrophoresis due to the lower mobility of ribonucleotides versus deoxynucleotides (Fig. 4b). Given that 
the Y100H mutant was identified in a tumor sample, we considered three different deoxy/ribo ratios, according 
to published data10,44: normal (1.5 µM dGTP + 273 µM GTP); pre-oncogenic (0.75 µM dGTP + 273 µM GTP), in 
which dNTP pools are below normal concentrations44; and oncogenic (7.2 µM dGTP + 273 µM GTP), in which 
Figure 4. Y100H variant is competent for re-priming in vivo. (a) Workflow of the experimental design 
to measure replication fork rate by DNA fiber analysis after downregulation of endogenous PrimPol and 
expression of exogenous wild-type (WT) PrimPol or Y100H mutant. Fork rate values were calculated from the 
green length of red-green tracks. N > 300 values in each condition; n.s.: non-significant; ***p < 0.001 (Mann-
Whitney test). Representative images of the different conditions are shown. (b) Dimer formation (primase 
assay) carried out using a 29-mer DNA template GTCA by either WT PrimPol or Y100H, in the presence of 
[γ-32P]ATP (16 nM) as the 5′nucleotide, and different physiological concentrations of either dGTP and GTP, as 
the incoming 3′nucleotide (normal cell concentration: 1.5 µM dGTP + 232 µM GTP, pre-oncogenic cell: 0.75 µM 
dGTP + 232 µM GTP or oncogenic cell: 7.2 µM dGTP + 232 µM GTP). The histogram shows the relative velocity 
of total dimer formation (AdG and AG) in the primase assays shown at the left. Full length gels corresponding 
to b are shown in Supplemental Fig. 7. The autoradiographs shown in this figure are representative of at least 3 
independent experiments.
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dNTP levels are increased over normal ratios10. Under these three conditions –in which GTP is 38- to 364-fold 
more abundant than dGTP– WT PrimPol mainly generated 3pAdG dimers (96%) due to its sugar selectivity 
against GTP, and the velocity of total dimer formation (calculated and normalized as described in Methods) was 
proportional to the concentration of dGTP (black bars in the histogram of Fig. 4b). Strikingly, the Y100H tumoral 
variant showed a complete switch from dGTP to GTP preference even at the highest (oncogenic) dGTP:GTP 
ratio, producing mainly 3pAG dimers (80%). Moreover, the Y100H variant showed a 4.5- to 7-fold increase in 
the total dimer formation rate (grey bars in the histogram of Fig. 4b) which can be taken as a measurement of its 
increased primase proficiency.
PrimPol Y100H enhances cellular resistance to dNTP pool depletion by reducing DSBs. The 
results shown above suggest that the Y100H variant is more proficient in cells than its WT counterpart, especially 
when dNTP levels are decreased, as it occurs in pre-oncogenic stages or following HU treatment (Fig. 5a, left 
panel). In agreement with previous reports in DT40 and HeLa cells39,42, MEFs lacking PrimPol were more sensi-
tive to chronic HU treatment (Supplemental Fig. 4a). As expected, Y100H ectopic expression in PrimPol-deficient 
MEFs significantly enhanced (up to 3-fold) resistance to chronic HU treatment when compared with the expres-
sion of similar amounts (Supplemental Fig. 4c) of WT PrimPol (Fig. 5a, central panels). To confirm these results, 
we used PrimPol-ablated U2OS osteosarcoma cells, which were also more sensitive to HU chronic treatment 
(Supplemental Fig. 4b). Again, ectopic expression of the Y100H variant in these cells enhanced their resistance 
to chronic HU treatment to slightly higher levels than WT PrimPol expressed at similar amounts (Fig. 5a, right 
panels; Supplemental Fig. 4d). To determine if this effect is specific to HU, we tested if the Y100H variant could 
promote a resistant phenotype to aphidicolin, an inhibitor of replicative polymerases from family B, as Polα, 
Polδ and Polε, and therefore causative of DNA replication stress. Firstly, we showed that aphidicolin decreased 
cell proliferation to a larger extent in PrimPol-KO than in PrimPol-WT MEFs (Supplemental Fig. 4e). However, 
unlike the experiment with HU, ectopic expression of PrimPol-Y100H rescued wild-type levels of sensitivity to 
aphidicolin (Supplemental Fig. 4f). Thus, the observed specificity for HU directly correlates the gain in using 
ribonucleotide substrates by Y100H with the selective deprivation of dNTPs induced by HU.
Replication forks stalled by HU frequently lead to double-strand breaks (DSBs) particularly in rapidly divid-
ing cells. Thus, we wondered if Y100H-expressing cells accumulate less DSBs, which could explain their higher 
resistance to HU. As expected, PrimPol-KO cells accumulated larger amounts of γ-H2AX foci (a marker of DSBs) 
than PrimPol-WT cells upon exposure to HU (Fig. 5b). Interestingly, ectopic expression of PrimPol-Y100H in 
HU-treated U2OS/PrimPol−/− cells significantly reduced γ-H2AX foci compared to cells expressing PrimPol-WT. 
This experiment suggests that in cells challenged by HU, and therefore deprived of dNTPs, the Y100H variant can 
use NTPs to fulfill its re-priming function, thus avoiding persisting RS and subsequent DSBs.
In conclusion, the specific advantage of the Y100H variant to generate primers, especially when dNTPs are 
limiting, could have been positively selected to alleviate the intense RS that is characteristic of many tumoral cells.
Discussion
Most DNA polymerases efficiently discriminate against NTP incorporation by virtue of an amino acid residue 
that acts as a steric gate, which, because of its bulky side chain, can sterically clash with the 2′-OH group of the 
incoming NTP, thereby hindering its binding and/or incorporation8,45. PrimPols from the different kingdoms of 
life are exceptional primases as they favor dNTPs over NTPs, as shown in Archaea31,32, Bacteria46,47 and Eukarya23. 
In this work we have identified human PrimPol Tyr100 as a mediator of sugar discrimination; however, our data 
suggest that it may not operate as a conventional steric gate as PrimPol does not discriminate against NTP incor-
poration as efficiently as other DNA polymerases such as replicases. Indeed, our results indicate that the Tyr100 
side chain is not only involved in steric clashing with the incoming NTP’s 2′-OH group, but it is also important 
for the architecture of the PrimPol active site and consequently for PrimPol activity. Accordingly, the mutation of 
Tyr100 to histidine enhanced NTP incorporation, but also decreased dNTP incorporation in most of our experi-
ments, reflecting its relevance for the overall activity of PrimPol. Interestingly, the crystal structure of MtPolDom, 
an AEP member with high affinity for NTPs, reveals a histidine residue located at an equivalent position to Tyr100 
that interacts with the 2′-OH of the incoming NTP (Fig. 1), suggesting that it favours the incorporation of these 
substrates. Indeed, the Y100H mutation dramatically increased the binding affinity of human PrimPol for NTPs, 
enhancing their incorporation in all in vitro reactions tested, and impacting PrimPol primase and TLS activities. 
Accordingly, the position occupied by Tyr100 appears to define sugar discrimination among AEP enzymes: those 
harbouring a tyrosine –such as HsPrimPol and Pfu-p41– likely favour dNTP incorporation, whereas members 
harbouring a histidine can proficiently incorporate NTPs.
The main role of PrimPol as a specific primase that mediates replication restart in eukaryotes poses the intriguing 
question of why, unlike conventional primases, does PrimPol discriminate against NTP incorporation? In other 
words, what is the advantage of making DNA primers over RNA primers? This could be possibly related to PrimPol 
efficient polymerase and TLS activities, a critical difference between PrimPols and other primases. It is worth noting 
that the RNA primers generated by the conventional eukaryotic primase must be converted by Polα into “DNA 
primers”, before they can be efficiently extended by Polδ and Polε. Conversely, PrimPol action is simplistic, as it pro-
vides a more ergonomic solution during unscheduled priming: the direct synthesis of a DNA primer, which is ready 
for elongation by a replicase. Another relevant question is whether the DNA primers made by PrimPol are partially 
removed or edited by the mismatch repair system; if this is not the case, PrimPol action could impose a certain level 
of mutagenesis, including bases substitutions and indels39 or the sporadic and limited insertion of ribonucleotides. 
It is tempting to speculate that lagging strand primases evolved from PrimPols by opening the steric gate, to validate 
NTPs as substrates. Thus, the more homogenous nature of the primers (all RNA) made by conventional primases 
could facilitate their elimination, minimizing mutagenesis, especially during lagging strand synthesis.
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Figure 5. PrimPol Y100H enhances cellular resistance to dNTP pool depletion by reducing DSBs. (a) Left 
panels: schematic representation of the effect of hydroxyurea (HU) in altering the dNTPs/NTPs ratio. Central/
upper panel: relative cell proliferation curves of PrimPol−/− MEFs transfected with empty vector (red), WT 
PrimPol (blue) or Y100H mutant (green), in the presence of increasing concentrations of HU (0.05, 0.10, 
0.15, 0.20 and 0.25 mM); histogram in the central/lower panel shows the ratio of cell proliferation relative to 
WT PrimPol−/− cells at three HU concentrations (0.05, 0.1 and 0.2 mM). Right upper panel: relative cell 
proliferation curves of PrimPol−/− U2OS cells transfected as described above, in the presence of increasing 
concentrations of HU (0.25, 0.5 and 1 mM); the histogram in the right lower panel shows the cell proliferation 
ratio relative to WT PrimPol−/− cells at the same HU concentrations. t test **p < 0.01. (b) Left: representative 
confocal microscopy images of DAPI and γH2AX stainings in U2OS cells or PrimPol KO cells transfected with 
empty vector, WT PrimPol or Y100H mutant. When indicated, cells were incubated with 0.25 mM HU. Right: 
top histogram indicates the average median value of γH2AX intensity in each condition, derived from three 
biological replicates (>100 cells scored per condition in each replicate). Statistical significance was assessed with 
ANOVA and Bonferroni post-test. All pair-wise differences between lanes 1–2 and 3–4, or between 5–6 and 
7–8, were significative. Bottom histogram depicts the fold-change difference in the intensity of γH2AX staining 
in the presence or absence of HU in each case.
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It is generally accepted that NTP incorporation and persistence in the DNA is a harmful situation for cells 
that is counteracted by the ribonucleotide excision repair (RER) pathway. This pathway operates in the nucleus, 
but not in mitochondria48, which explains the abundance of embedded NMPs in mitochondrial DNA. Several 
pathologies are related to the alteration of mechanisms that prevent NTP incorporation or remove inserted NTPs, 
due to: (1) an increase in the NTP/dNTP ratio inside the nucleus and/or mitochondria, as occurs by aberrant 
activation of the retinoblastoma (Rb) E2F pathway (Rb-E2F), by either viral (HPV-16 E6/E7) or cellular (cyclin E) 
oncogenes44, or in Mpv17-related disorders that provoke a low dGTP concentration in liver mitochondria49; (2) 
mutation of specific components of the RER pathway, thus allowing persistence of embedded NMPs into DNA 
causing a severe phenotype as occurs in the RNase H2-deficient mouse12,50. In addition, it is also possible that 
specific mutations affecting the steric gates of DNA polymerases could have a pathological effect, mediated by 
an increase in embedded NMPs into DNA. We show here that human PrimPol can be converted into a “conven-
tional” primase just by a single mutation (Y100H) at the sugar selector residue Tyr100. The RNA primers made by 
the Y100H variant appear to be functional to re-start stalled replication forks, and are synthesized with a higher 
efficiency specially in conditions of dNTP deprivation. These observations pose some intriguing questions: are 
these Y100H/PrimPol-made RNA primers eliminated as normal RNA primers of the lagging strand, or could they 
be targeted by the RER pathway? If not, would they contribute to genome instability? Interestingly, the Y100H 
mutation has been described in tumour cells and is compiled in the COSMIC database30,38. This could suggest 
that ablating the ability of PrimPol to discriminate against NTPs could promote survival during tumorigenesis. 
Accordingly, Y100H expression in MEFs or U2OS cells increased resistance against dNTP partial depletion with 
chronic sublethal treatment with HU, which mimics incipient tumorigenesis stages where dNTP concentration 
is low44. It is therefore tempting to speculate that the Y100H mutation could be selected early in tumorigenesis 
to deal with low dNTP levels, and to preclude DSBs caused by persistent replicative stress. Finally, given the 
dramatic effect on the dNTP/NTP discrimination factor of PrimPol variant Y100H, a relevant question would be 
wether the frequency of embedded ribonucleotides is increased in cells carrying the Y100H mutation at pretu-
moral lesions. If so, this could have caused the genomic instability that led to the cancerous state.
Finally, expression of the Y100H mutant in an RER-deficient background could be a valuable experimental 
approach to further explore the processes underlying replication re-start in mammals, and the role of PrimPol 
during mitochondrial DNA replication – the mechanistic details of which are still under debate48,51.
Materials and Methods
primary sequence alignments, structure visualization and modelling of Aep primases. Multiple 
sequence alignments were performed using COBALT (constraint-based multiple alignment tool)52,53 from the 
National Center for Biotechnology Information (NCBI). Three-dimensional images were created with the PyMol 
Molecular Graphics System (version 1.2r3pre, Schrödinger, LLC) using HsPrimPol PDB ID: 5L2X34, Pfu-p41 PDB 
ID: 1G7133, and MtPolDom PDB ID: 3PKY36. A ternary complex of Pfu-p41 with DNA template and primer strands 
and incoming nucleotide was modeled by fitting HsPrimPol PDB ID: 5L2X to Pfu-p41 PDB ID: 1G71 (using the 
three invariant catalytic aspartates (motifs A and C) and the invariant histidine (motif B) as common coordinates). A 
ternary complex of MtPolDom was modelled by combining the protein structure and the incoming nucleotide from 
PDB ID: 3PKY, and DNA template/primer from PDB ID: 4MKY37. Both PDB structures of MtPolDom were fitted by 
aligning the three invariant catalytic aspartates (motifs A and C) and the invariant histidine (motif B).
oligonucleotides, nucleotides and antibodies. DNA and RNA oligonucleotides were synthesized by 
Sigma Aldrich (St Louis, MO, USA). Unlabelled ultrapure dNTPs were supplied by GE (Fairfield, CT, USA). 
Radiolabeled nucleotides [γ-32P]ATP, [α-32P]dATP and [α-32P]dGTP (3000 Ci/mmol) were obtained from Perkin 
Elmer (Waltham, MA, USA). T4 polynucleotide kinase used for 5′ labeling of oligonucleotides was supplied by 
New England Biolabs (Ipswich, MA, USA). Anti-human PrimPol antibody (1:1000 dilution) was generated by 
ThermoFisher (Waltham, MA, USA). Secondary antibody ECLTM Anti-Rabbit IgG was detected by LuminataTM 
Forte Western HRP Substrate in MEFS (GE Healthcare). PrimPol in U2OS cells was detected by LI-COR second-
ary antibodies IRDye 800CW and IRDye 680RD using Odyssey equipment.
Mutagenesis and enzyme purification. The coding Y100H point mutation in the WT PrimPol gene 
was introduced by PCR using the QuickChange site-directed mutagenesis kit (Stratagene, San Diego, CA, USA), 
using the vector pET16b:CCDC11123 as template and the following primers: 5′CAGAAAAAATCTCTTACA 
CTGCCATGAAGTTATTCCTGAAAATGC-3′ and 5′-GCATTTTCAGGAATAACTTCATGGCAGTGTAAG 
AGATTTTTTCTG-3′. Overexpression and purification of both WT PrimPol and Y100H variant was carried out 
as previously described23.
Polymerase assay on specific template/primer molecules. Oligonucleotides used as primers were 
labelled with PNK and [γ-32P]ATP as indicated by the manufacturer, and hybridized with the correspond-
ing template in a 1:2 stoichiometry, in 50 mM Tris pH 7.5 and 300 mM NaCl. The following template/primer 
structures were used: (1) 28-mer DNA template (5′-AGAAGTGTATCXCGTACTCACTGTGATC-3′, where X is dA, 
dC, dG or dT) / [γ-32P]-labelled 15-mer DNA primer (5′-GATCACAGTGAGTAC-3′) or RNA primer (5′-GAUCACA 
GUGAGUAC-3′); (2) 34-mer DNA template (5′-GTACCCGGGGATCCGTACXGCGCATCAGCTGCAG-3′)/ 
[γ-32P]-labelled 15-mer DNA primer (5′-CTGCAGCTGATGCGC-3′ where X is dG, dT or 8oxoG); (3) 45-mer 
DNA template with a CPD thymine dimer at T = T (5′-AGGATAGTGACAGTAGTGTATGT = TATAGTCAG 
TATGATCGTACGG-3′)/[γ-32P]-labelled 15-mer DNA primer (5′-CCGTACGATCATACTGACTAT-3′).
The reactions (20 μL) were carried out in buffer R (50 mM Tris-HCl [pH 7.5], 50 mM NaCl, 1 mM MnCl2, 
1 mM DTT, 2.5% glycerol and 0.1 mg/ml bovine serum albumin) with 2.5 nM template/primer DNA, increas-
ing concentrations of dNTPs or NTPs and 200 nM of either WT PrimPol or Y100H mutant, unless indicated 
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otherwise. After 20 min at 30 °C, reactions were stopped by the addition of formamide loading buffer (95% for-
mamide, 10 mM EDTA, 0.1% bromophenol blue and 0.1% xylene-cyanol) and loaded in and 8 M urea-containing 
20% polyacrylamide sequencing gel. Autoradiography was used to detect primer extension products.
steady-state kinetics assay. Kinetic parameters of + 1 nt primer extension reactions mediated by either 
WT PrimPol or mutant Y100H were analyzed as described previously17,54. The reaction mixture (20 µL) con-
tained, in buffer R: 0.2 M of the 28-mer template/primer structure described above and 40 nM WT PrimPol 
or Y100H variant. Reactions were incubated at 30 °C during 7 min in the case of WT PrimPol with dNTPs and 
Y100H with dNTPs or NTPs. WT PrimPol was incubated with NTPs during 10 min at 30°C. Reactions were 
stopped and resolved as described above. Gel band intensities were analyzed using a BAS reader 1500 (Fujifilm). 
Autoradiographs were quantitated by densitometry using ImageJ software (NIH). The observed rate of nucleo-
tide incorporation (extended primer) was plotted as a function of nucleotide concentration. Data were fit to the 
Michaelis–Menten equation using non-linear regression to determine the apparent Km and kcat parameters.
Primase assays on specific oligonucleotide templates. The reaction mixture (20 µL) contained, 
in buffer R: [α-32P]dATP or [γ-32P]ATP (16 nM) as 5′ site nucleotide, increasing concentrations of dGTP 
or GTP (or both) as 3′site nucleotide, in the presence of WT PrimPol or Y100H variant (400 nM). The oligo-
nucleotides used as templates (1 µM) were: 29-mer 5′ -T15ACTGT10-3′ (abbreviated as GTCA) and 60-mer 
5′-T20ACGACAGACTGT29 -3′. After 20 min at 30 °C, reactions were stopped as described above. When indi-
cated, different reaction times were used to obtain velocities. After electrophoresis, de novo synthesized dimers 
were detected by autoradiography and quantitated by densitometry as described above.
electrophoretic mobility shift assays. Interaction of PrimPol and ssDNA template was carried out 
in buffer R (supplemented with 2.5% (w/v) PEG-4000), by mixing 1 nM of labelled GTCC oligonucleotide 
(5′ -T36CCTGT20-3′) and increasing concentrations of WT PrimPol or Y100H variant. Reactions were incubated 
for 10 min at 30 °C and then stopped by adding loading buffer (50% glycerol, 1 mM EDTA, 0.1% xylene cyanol 
and 0.1% bromophenol blue). Immediately, reactions were loaded in a native 6% polyacrylamide gel, and run at 
150 V at 4 °C for 120 min in Tris-glycine pH 8.3 buffer. After electrophoresis, the binary complex protein/DNA 
and free DNA were detected by autoradiography. EMSA for pre-ternary complex formation was carried in buffer 
R with 2.5% (w/v) PEG-4000, non-labelled oligo GTCC (500 nM), WT PrimPol or Y100H mutant (1 µM), and 
the labelled nucleotide [α-32P]dGTP or [α-32P]GTP (16 nM). Mixtures (20 µL) were incubated for 30 min at 30 °C. 
Then, loading buffer was added and enzyme:DNA:d/NTP pre-ternary complex was analyzed as described above.
single-molecule analysis of DNA replication in stretched DNA fibers. The stable cell line 
HeLa-shPrimPol has been described before24. DNA sequences encoding WT PrimPol and Y100H variant were 
cloned into Gateway expression vectors (Invitrogen) introducing an N-terminal V5 tag. Transient transfection 
was performed using Lipofectamine 2000 (ThermoFisher, Waltham, MA, USA). HeLa-shPrimPol cells grow-
ing exponentially in culture were pulse-labelled with 50 μM CldU (20 min) followed by 250 μM IdU (20 min). 
Labelled cells were harvested and resuspended in phosphate buffered saline at 0.25 × 106 cells/mL. Stretched DNA 
fibers were prepared as described55 with minor modifications. A detailed protocol is available upon request. For 
immunodetection of labelled tracks, fibers were incubated with primary antibodies anti-CldU (rat monoclonal 
anti-BrdU, Abcam #AB6326) and anti-IdU (mouse monoclonal anti-BrdU, BD Biosciences #347580) for 1 h at 
RT and the corresponding Alexa Fluor-conjugated secondary antibodies (Invitrogen/Molecular Probes #A-11007 
and A-21121) for 30 min, both at room temperature in a humidity chamber. DNA was stained with anti-ssDNA 
(Millipore, #MAB3034) to assess fiber integrity. Fiber images were obtained in a DM6000 B Leica microscope. 
Fork rate was estimated from > 300 red-green tracks per condition using conversion factor 1 μm = 2.59 kb56.
Cell proliferation assays in the presence of hydroxyurea or aphidicolin. MEFs derived from 
PrimPol−/− mice and PrimPol−/− U2OS cells generated by CRISP-Cas9 editing were cultured in Dulbecco’s 
Modified Eagle Medium (Life Technologies, Carslbad, CA, USA) supplemented with 10% HyClone fetal bovine 
serum (ThermoFisher, Waltham, MA, USA) and 1% penicillin and streptomycin (Life Technologies, Carlsbad, 
CA, USA). Cells were seeded in p24 plates at 3 × 104 cells per well and transfected with empty pcDNA3.1(-) 
or pcDNA:CCDC111 encoding WT PrimPol or the Y100H variant. TurboFect Transfection Reagent or 
Lipofectamine 2000 was used for MEFs and U2OS, respectively (ThermoFisher, Waltham, MA, USA). After 48 h, 
cells were treated with the indicated concentrations of HU (Sigma Aldrich, St Louis, MO, USA) during 24 h 
(MEFs) or 48 h (U2OS) or with APH (Sigma Aldrich, St Louis, MO, USA) during 24 h (MEFs). Cells were fixed 
with 10% formaldehyde for 30 min and relative cell proliferation was assessed by crystal violet staining.
Quantification of DNA damage by γH2AX staining. WT U2OS or isogenic PrimPol KO cells, grown 
on DMEM-10% fetal bovine serum supplemented with penicillin/streptomycin, were transfected with 2 ug of 
pcDNA3.1-based plasmids expressing either V5-PrimPol or V5-PrimPol Y100H. 24 h after transfection, cells were 
seeded in Opera Greiner microclear plates (6000 cells/well). 0.25 mM HU was added to the medium for 48 h. Cells 
were pre-extracted for 5 min in ice with 0.5% Triton X-100 in CSK buffer (10 mM PIPES pH 7.0, 0.1 M NaCl, 0.3 M 
sacarose, 3 mM MgCl2, 0.5 mM PMSF) and fixed with 4% paraformaldehyde for 15 min. Immunofluorescence 
detection of γH2AX was preceded by a 30 min incubation in blocking solution (3% BSA in phosphate-buffered 
saline containing 0.01% Tween). γH2AX antibody (EMD Millipore 05–636; 1:200 in blocking solution) was added 
for 1 h at RT. Secondary antibody AF-488 anti-mouse IgG (1:300 in blocking solution) was added for 1 h at RT. 
Nuclei were counterstained with DAPI. Images were analyzed in an Opera high-content screening system (Perkin 
Elmer): γH2AX intensity was measured within the nuclei mask and quantified using Acapella software.
www.nature.com/scientificreports/
1 2Scientific RepoRts |          (2019) 9:1121  | https://doi.org/10.1038/s41598-018-37439-0
References
 1. Clausen, A. R., Murray, M. S., Passer, A. R., Pedersen, L. C. & Kunkel, T. A. Structure–function analysis of ribonucleotide bypass by 
B family DNA replicases. Proc Natl Acad Sci USA 110, 16802–16807 (2013).
 2. Nick McElhinny, S. A. et al. Abundant ribonucleotide incorporation into DNA by yeast replicative polymerases. Proc Natl Acad Sci 
USA 107, 4949–4954 (2010).
 3. Watt, D. L., Johansson, E., Burgers, P. M. & Kunkel, T. A. Replication of ribonucleotide-containing DNA templates by yeast 
replicative polymerases. DNA Repair (Amst) 10, 897–902 (2011).
 4. Hovatter, K. R. & Martinson, H. G. Ribonucleotide-induced helical alteration in DNA prevents nucleosome formation. Proc Natl 
Acad Sci USA 84, 1162–1166 (1987).
 5. Li, Y. & Breaker, R. R. Kinetics of RNA degradation by specific base catalysis of transesterification involving the 2′-hydroxyl group. 
J Am Chem Soc. 121, 5364–5372 (1999).
 6. Gao, R. et al. Proteolytic degradation of topoisomerase II (Top2) enables the processing of Top2·DNA and Top2·RNA covalent 
complexes by Tyrosyl-DNA-Phosphodiesterase 2 (TDP2). The J Biol Che 289, 17960–17969 (2014).
 7. Tumbale, P., Williams, J. S., Schellenberg, M. J., Kunkel, T. A. & Williams, R. S. Aprataxin resolves adenylated RNA-DNA junctions 
to maintain genome integrity. Nature 506, 111–115 (2014).
 8. Joyce, C. M. Choosing the right sugar: How polymerases select a nucleotide substrate. Proc Natl Acad Sci USA 94, 1619–1622 (1997).
 9. Clausen, A. R., Zhang, S., Burgers, P. M., Lee, M. Y. & Kunkel, T. A. Ribonucleotide incorporation, proofreading and bypass by 
human DNA polymerase δ. DNA Repair (Amst) 12, 121–127 (2013).
 10. Traut, T. W. Physiological concentrations of purines and pyrimidines. Mo Cell Biochem 140, 1–22 (1994).
 11. Williams, J. S. et al. Proofreading of ribonucleotides inserted into DNA by yeast DNA polymerase ε. DNA Repair (Amst) 11, 649–656 
(2012).
 12. Reijns, M. A. M. et al. Enzymatic removal of ribonucleotides from DNA is essential for mammalian genome integrity and 
development. Cell 149, 1008–1022 (2012).
 13. Sparks, J. L. et al. RNase H2-Initiated Ribonucleotide Excision Repair. Mol Cell 47, 980–986 (2012).
 14. Ghodgaonkar, M. M. et al. Ribonucleotides misincorporated into DNA act as strand-discrimination signals in eukaryotic mismatch 
repair. Mol Cell 50, 323–332 (2013).
 15. Lujan, S. A., Williams, J. S., Clausen, A. R., Clark, A. B. & Kunkel, T. A. Ribonucleotides are signals for mismatch repair of leading-
strand replication errors. Mol Cell 50, 437–443 (2013).
 16. Martin, M. J., Garcia-Ortiz, M. V., Esteban, V. & Blanco, L. Ribonucleotides and manganese ions improve non-homologous end 
joining by human Polµ. Nucleic Acids Res 41, 2428–2436 (2013).
 17. Sastre-Moreno, G., Sánchez, A., Esteban, V. & Blanco, L. ATP insertion opposite 8-oxo-deoxyguanosine by Pol4 mediates error-free 
tolerance in Schizosaccharomyces pombe. Nucleic Acids Res 42, 9821–9837 (2014).
 18. Sayrac, S., Vengrova, S., Godfrey, E. L. & Dalgaard, J. Z. Identification of a novel type of spacer element required for imprinting in 
fission yeast. PLoS Genet 7, e1001328 (2011).
 19. Vaisman, A. & Woodgate, R. Ribonucleotide discrimination by translesion synthesis DNA polymerases. Crit Rev Biochem Mol Biol 
Jul 4, 1–21 (2018).
 20. Scherzinger, E. & Seiffert, D. Studies on bacteriophage T7 DNA synthesis in vitro. I. Resolution of the T7 replication system into its 
components. Mol Gen Genet 141, 213–232 (1975).
 21. Scherzinger, E., Lanka, E., Morelli, G., Seiffert, D. & Yuki, A. Bacteriophage-T7-induced DNA-priming protein. A novel enzyme 
involved in DNA replication. Eur J Biochem 72, 543–58 (1977).
 22. Rowen, L. & Kornberg, A. Primase, the dnaG protein of Escherichia coli. An enzyme which starts DNA chains. J Biol Chem 253, 
758–764 (1978).
 23. García-Gómez, S. et al. PrimPol, an Archaic Primase/Polymerase Operating in Human Cells. Mol Cell 52, 541–553 (2013).
 24. Mourón, S. et al. Repriming of DNA synthesis at stalled replication forks by human PrimPol. Nat Struct Mol Biol 20, 1383–1389 
(2013).
 25. Wan, L. et al. hPrimpol1/CCDC111 is a human DNA primase-polymerase required for the maintenance of genome integrity. EMBO 
Rep 14, 1104–1112 (2013).
 26. Schiavone, D. et al. PrimPol Is Required for Replicative Tolerance of G Quadruplexes in Vertebrate Cells. Mol Cell 61, 161–169 
(2016).
 27. Šviković,S. et al. S phase R-loop formation is restricted by PrimPol-mediated repriming. Preprint at https://www.biorxiv.org/
content/early/2018/05/09/318220 (2018).
 28. Torregrosa-Muñumer, R. et al. (2017) Primpol is required for replication re-initiation after mitochondrial damage. Proc Natl Aca Sci. 
USA 114(11403), 11398 (2017).
 29. Martínez-Jiménez, M. I., Calvo, P. A., García-Gómez, S., Guerra-González, S. & Blanco, L. The Zn-finger domain of human PrimPol 
is required to stabilize the initiating nucleotide during DNA priming. Nucleic Acids Res 46, 4138–4151 (2018).
 30. Liu, J. et al. Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events. Genome Res 22, 
2315–2327 (2012).
 31. Bocquier, A. A. et al. Archaeal primase: bridging the gap between RNA and DNA polymerases. Curr Biol 11, 452–456 (2001).
 32. Liu, L. et al. The archaeal DNA primase: biochemical characterization of the p41-p46 complex from Pyrococcus furiosus. J Bio Chem 
276, 45484–45490 (2001).
 33. Augustin, M. A., Huber, R. & Kaiser, J. T. Crystal structure of a DNA-dependent RNA polymerase (DNA primase). Nat Struct Biol 
8, 57–61 (2001).
 34. Rechkoblit, O. et al. Structure and mechanism of human PrimPol, a DNA polymerase with primase activity. Sci Adv 2, e1601317 
(2016).
 35. Pitcher, R. S. et al. Structure and function of a mycobacterial NHEJ DNA repair polymerase. J Mol Biol 366, 391–405 (2007).
 36. Brissett, N. C. et al. Structure of a preternary complex involving a prokaryotic NHEJ DNA polymerase. Mol Cell 41, 221–231 (2011).
 37. Brissett, N. C. et al. Molecular Basis for DNA Double-Strand Break Annealing and Primer Extension by an NHEJ DNA Polymerase. 
Cell Rep 5, 1108–1120 (2013).
 38. Bamford, S. et al. The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. Br J Cancer 91, 355–358 (2004).
 39. Martínez-Jiménez, M. I. et al. Alternative solutions and new scenarios for translesion DNA synthesis by human PrimPol. DNA 
Repair (Amst) 29, 127–138 (2015).
 40. Keen, B. A., Jozwiakowski, S. K., Bailey, L. J., Bianchi, J. & Doherty, A. J. Molecular dissection of the domain architecture and 
catalytic activities of human PrimPol. Nucleic Acids Res 42, 5830–5845 (2014).
 41. Zafar, M. K., Ketkar, A., Lodeiro, M. F., Cameron, C. E. & Eoff, R. L. Kinetic analysis of human PrimPol DNA polymerase activity 
reveals a generally error-prone enzyme capable of accurately bypassing 7,8-Dihydro-8-oxo-2′-deoxyguanosine. Biochemistry 53, 
6584–6594 (2014).
 42. Tokarsky, E. J., Wallenmeyer, P. C., Phi, K. K. & Suo, Z. Significant impact of divalent metal ions on the fidelity, sugar selectivity, and 
drug incorporation efficiency of human PrimPol. DNA Repair (Amst) 49, 51–59 (2017).
 43. Kobayashi, K. et al. Repriming by PrimPol is critical for DNA replication restart downstream of lesions and chain-terminating 
nucleosides. Cell Cycle 15, 1997–2008 (2016).
www.nature.com/scientificreports/
13Scientific RepoRts |          (2019) 9:1121  | https://doi.org/10.1038/s41598-018-37439-0
 44. Bester, A. C. et al. Nucleotide deficiency promotes genomic instability in early stages of cancer development. Cell 145, 435–446 
(2011).
 45. Brown, J. A. & Suo, Z. Unlocking the Sugar “Steric Gate” of DNA Polymerases. Biochemistry 50, 1135–1142 (2011).
 46. Picher, A. J. et al. TruePrime is a novel method for whole-genome amplification from single cells based on TthPrimPol. Nat Commun 
7, 13296 (2016).
 47. Sánchez-Berrondo, J. et al. Molecular architecture of a multifunctional MCM complex. Nucleic Acids Res 40, 1366–1380 (2012).
 48. Wanrooij, P. H. et al. Ribonucleotides incorporated by the yeast mitochondrial DNA polymerase are not repaired. Proc Natl Acad Sci 
USA 114, 12466–12471 (2017).
 49. Moss, C. F. et al. Aberrant ribonucleotide incorporation and multiple deletions in mitochondrial DNA of the murine MPV17 disease 
model. Nucleic Acids Res 45, 12808–12815 (2017).
 50. Hiller, B. et al. Mammalian RNase H2 removes ribonucleotides from DNA to maintain genome integrity. J Exp Med 209, 1419–1426 
(2012).
 51. Stojkovic, G. et al. Oxidative DNA damage stalls the human mitochondrial replisome. Sci Re 6, 28942 (2016).
 52. Papadopoulos, J. S. & Agarwala, R. COBALT: constraint-based alignment tool for multiple protein sequences. Bioinformatics 23, 
(1073–1079 (2007).
 53. Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9, 671–675 (2012).
 54. Creighton, S. & Goodman, M. F. Gel kinetic analysis of DNA polymerase fidelity in the presence of proofreading using bacteriophage 
T4 DNA polymerase. J Biol Chem 270, 4759–4774 (1995).
 55. Terret, M. E., Sherwood, R., Rahman, S., Qin, J. & Jallepalli, P. V. Cohesin acetylation speeds the replication fork. Nature 462, 
231–234 (2009).
 56. Jackson, D. A. & Pombo, A. Replicon clusters are stable units of chromosome structure: evidence that nuclear organization 
contributes to the efficient activation and propagation of S phase in human cells. J Cell Biol 140, 1285–1295 (1998).
Acknowledgements
We are thankful to Professor Ian J. Holt (BioDonostia, San Sebastian, Spain), for critical reading of the manuscript. 
We thank Sara Rodriguez-Acebes (CNIO) for advice regarding the assays with stretched DNA fibers. This study 
was funded by the Spanish Ministry of Economy and Competitiveness (MINECO; BFU2012–3769, BFU2014–
51672-REDC and BFU2015–65880-P (co-funded with European Union FEDER funds) to L.B.; BFU2013–
49153-P and BFU2016–80402-R (co-funded with European Union FEDER funds) to J.M.). A.D.T., P.A.C. and 
D.G.A. are recipients of MINECO FPI-predoctoral fellowships. M.D. was the recipient of a FPI-predoctoral 
fellowship from Programa de Excelencia “Severo Ochoa” (CNIO-MINECO). G.S.M was the recipient of a JAE 
Predoctoral Fellowship from the Spanish Research Council (CSIC). Funding for open access charge: Spanish 
MINECO [BFU2015–65880-P].
Author Contributions
A.D.T. performed primary sequence alignments, structure visualization and modelling. L.B.F., S.G., M.I.M.J. 
and A.D.T. constructed the vectors for Y100H mutant and purified the proteins. D.G.A. obtained the U2OS 
PrimPol −/− cells. A.D.T. and P.A.C. performed the in vitro experiments. M.D. and J.M. performed the DNA 
fiber analyses. A.D.T. and D.G.A. performed cell proliferation and gH2AX detection assays. L.B, M.I.M.J., and 
J.M. conceived and supervised the experiments. The paper was written by L.B., A.D.T. and G.S.M.
Additional Information
Supplementary information accompanies this paper at https://doi.org/10.1038/s41598-018-37439-0.
Competing Interests: The authors declare no competing interests.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2019
